New York A01321 expands collaborative drug therapy management to include nurse practitioners and makes pharmacists' authorization permanent.

New York A01321 amends the education law to include nurse practitioners as providers for collaborative drug therapy management. This bill also makes permanent the authorization for pharmacists to perform such management. Collaborative drug therapy management involves pharmacists reviewing, evaluating, and managing drug therapy for patients under a written agreement with a physician or nurse practitioner. The bill ensures that participation is voluntary and that patients' consent is required in writing. Pharmacists must meet specific education and experience requirements to participate.

New York A01321 expands collaborative drug therapy management to include nurse practitioners and makes pharmacists' authorization permanent.

New York A01321 amends the education law to include nurse practitioners as providers for collaborative drug therapy management. This bill also makes permanent the authorization for pharmacists to perform such management. Collaborative drug therapy management involves pharmacists reviewing, evaluating, and managing drug therapy for patients under a written agreement with a physician or nurse practitioner. The bill ensures that participation is voluntary and that patients' consent is required in writing. Pharmacists must meet specific education and experience requirements to participate.